Retroscreen Virology Purchases ALPHADAS for Clinical Studies across Multiple Sites

Retroscreen Virology Purchases ALPHADAS for Clinical Studies across Multiple Sites

ALPHADAS EDC Selected to Accelerate Clinical Trial Operations and Service Across Multiple Sites

CONSHOHOCKEN, PA - (BUSINESS WIRE) – July 31 , 2013 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the operating subsidiary of  Retroscreen Virology Group PLC (AIM: RVG, "Retroscreen") has purchased the ALPHADAS® clinical trials software suite to assist in its mission to accelerate and reduce the cost of bringing anti-viral drugs, diagnostics, and vaccines to market.

Instem's ALPHADAS software solution suite is a proactive eSource clinical research and early phase trials system that is mobile, schedule-driven, and provides real-time bedside or station based direct data capture that virtually eliminates paper-based data.

Retroscreen conducted a comprehensive evaluation, as a result of which ALPHADAS was selected for its ability to immediately increase efficiencies and quality through direct data capture from Retroscreen instrumentation, to manage and monitor samples through the entire study lifecycle while offering real-time data review.  

On behalf of its sponsors, Retroscreen conducts the Human Viral Challenge Model in a controlled quarantine environment, providing a cost-effective study design which critically accelerates the selection of a safe and effective dose, and dosing regimen, for a new antiviral drug or vaccine.

The data captured by the ALPHADAS system during these specialized studies will facilitate Retroscreen's continued extensive characterization of the safety, pathogenicity and virulence of its viruses, and importantly, the nature of the disease they cause.

Further efficiencies will also be delivered through ALPHADAS from enhancing Retroscreen's comprehensive volunteer recruitment process, providing complete and complex chain of custody for samples through to real-time remote data review.

Key facts

  • ALPHADAS chosen for its ease of use and ability to provide immediate ROI for specialized Human Viral Challenge Studies
  • Retroscreen to utilize ALPHADAS eSource data capture – both on and offline (critical for timed data) & including medical device integrations,  real time & remote data review
  • ALPHADAS also to be used for accelerated recruitment, staff resourcing and site management operations

"We are excited to be implementing ALPHADAS and look forward to the benefits throughout our organization," comments Kym Denny, CEO of Retroscreen. "From recruitment to finance, and from the clinic floor to our sample tracking, it's evident that we will be quickly enhancing the level of service to our sponsors as a result."

Giles Wilson, Head of Instem Clinical & SVP commented, "When the protocol is entered into ALPHADAS, it is not only for data collection – it also drives the workflows and operational efficiencies that deliver a significant and immediate ROI. This proved compelling for Retroscreen." Wilson continued, "Along with the entire original Logos Technologies team, now operating as Instem Clinical, I am looking forward to a long and successful partnership with Retroscreen as they continue their mission to fight against a wide variety of viral diseases."

About Retroscreen Virology 
Retroscreen is a virology healthcare business that provides clinical services, focused on the Viral Challenge Model ("VCM"), and pre-clinical analytical services, primarily to global pharmaceutical companies and biotechnology organizations. Retroscreen has grown and developed the VCM for evidencing the efficacy of antiviral and viral therapeutics in influenza, HRV (cold) and RSV viruses.

Retroscreen is focused on revenue growth, building capacity and pioneering a new way to conduct clinical trials in the development of drugs against virus, with the goal of dominating its space and pushing the bounds of scientific knowledge and understanding in virology.

To learn more about Retroscreen, visit www.retroscreen.com.

  
About Instem 
Instem is a leading supplier of IT applications to the early development healthcare market deliveringcompelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processeswhile offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com

Meeting clients at the intersection of investment & return™.

Press Contacts:
Instem
Gary Mitchell (US HQ)
[email protected] 
Tel: 610-941-0990

Julie Jones (UK HQ)
[email protected] 
Tel: +44 (0) 1785 825600

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.